BUSINESSQUARTZ
AbbVie beat profit estimates but cut its forecast — and the stock sank
AbbVie exceeded second-quarter profit estimates due to strong immunology sales but reduced its full-year adjusted earnings outlook, leading to a stock price decline.
Mentioned
Related Signal
Adjacent reporting
- Vertiv beat earnings expectations and raised its outlook — but the stock sank
- Accenture stock sinks after cutting its full-year revenue forecast
- Stellantis swung to a profit from a year-ago loss, but the stock sank on weak margins
- Bank of America stock falls despite earnings beat
- Procter & Gamble's sales missed expectations as shoppers traded down — and the stock sank
- Zillow Shares Drop As Profit Outlook Miss Overshadows Upbeat 1Q